Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illinois Tool Works
ITW
|
+$224M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$199M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$129M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$116M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$1.15B |
| 3 |
NVIDIA
NVDA
|
+$628M |
| 4 |
Amazon
AMZN
|
+$524M |
| 5 |
Tesla
TSLA
|
+$355M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.4% |
| 2 | Financials | 11.58% |
| 3 | Healthcare | 11.43% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Consumer Portfolio Services
CPSS
$202M
| $598K | ﹤0.01% |
79,109
-786
| -1% | -$6.71K |
|
3502
Noodles & Co
NDLS
$111M
| $598K | ﹤0.01% |
39,119
-1,973
| -5% | -$38.5K |
|
|
SWKH
3503
DELISTED
SWK Holdings
SWKH
| $597K | ﹤0.01% |
43,260
-429
| -1% | -$5.77K |
|
3504
BioXcel Therapeutics
BTAI
$24.9M
| $597K | ﹤0.01% |
13,225
-862
| -6% | -$41.1K |
|
3505
Vuzix
VUZI
$194M
| $594K | ﹤0.01% |
491,019
-10,629
| -2% | -$17.3K |
|
|
NGM
3506
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $593K | ﹤0.01% |
372,733
+35,451
| +11% | +$52.6K |
|
|
CMRX
3507
DELISTED
Chimerix, Inc.
CMRX
| $592K | ﹤0.01% |
558,486
-131,831
| -19% | -$137K |
|
3508
Atara Biotherapeutics
ATRA
$75.5M
| $590K | ﹤0.01% |
34,033
+216
| +0.6% | +$3.84K |
|
|
NOAH
3509
Noah Holdings
NOAH
$580M
| $590K | ﹤0.01% |
51,657
+20,960
| +68% | +$243K |
|
3510
Smith-Midland
SMID
$144M
| $588K | ﹤0.01% |
12,515
-710
| -5% | -$28.9K |
|
|
USAP
3511
DELISTED
Universal Stainless & Alloy
USAP
| $585K | ﹤0.01% |
26,083
-144
| -0.5% | -$2.91K |
|
3512
The Honest Company
HNST
$402M
| $579K | ﹤0.01% |
143,085
+1,556
| +1% | +$5.25K |
|
3513
Prelude Therapeutics
PRLD
$366M
| $579K | ﹤0.01% |
122,147
+8,050
| +7% | +$31.3K |
|
3514
LifeMD
LFMD
$169M
| $578K | ﹤0.01% |
56,178
| – | – |
|
3515
Protalix BioTherapeutics
PLX
$191M
| $577K | ﹤0.01% |
458,145
-36,092
| -7% | -$53.9K |
|
3516
JPMorgan BetaBuilders Japan ETF
BBJP
$17.5B
| $576K | ﹤0.01% |
+9,833
| New | +$546K |
|
3517
PMV Pharmaceuticals
PMVP
$59.2M
| $575K | ﹤0.01% |
338,134
+10,910
| +3% | +$20.4K |
|
3518
ProKidney
PROK
$316M
| $573K | ﹤0.01% |
349,357
-29,861
| -8% | -$43.9K |
|
3519
Canadian Solar
CSIQ
$1.02B
| $571K | ﹤0.01% |
28,914
-323
| -1% | -$6.96K |
|
|
CLPR
3520
Clipper Realty
CLPR
$45.2M
| $568K | ﹤0.01% |
117,498
-5,239
| -4% | -$25.9K |
|
3521
Natural Gas Services Group
NGS
$472M
| $567K | ﹤0.01% |
29,194
+40
| +0.1% | +$644 |
|
3522
AEON Biopharma
AEON
$12.9M
| $566K | ﹤0.01% |
678
-14
| -2% | -$10.1K |
|
3523
Smartbird Inc
BIRD
$19.5M
| $565K | ﹤0.01% |
40,666
+164
| +0.4% | +$3.06K |
|
3524
Ramaco Resources Class B
METCB
$425M
| $562K | ﹤0.01% |
48,284
+953
| +2% | +$10.9K |
|
|
SHCO
3525
DELISTED
Soho House & Co
SHCO
| $560K | ﹤0.01% |
98,689
-5,485
| -5% | -$33.2K |
|
Similar funds
Northern Trust's Q1 2024 Portfolio in Review
As of Q1 2024, Northern Trust held 4,565 positions worth $579B, up 4.8% from $552B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Northern Trust withdrew a net $22.5B in Q1 2024, closing 140 positions and reducing 3,160 holdings. Its most notable exit was Splunk Inc, an estimated $163M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Northern Trust opened a new position in Arcadium Lithium plc worth $50.1M.
- Northern Trust's largest Q1 2024 buy was Arcadium Lithium plc: 11,618,079 shares worth $50.1M.
- Northern Trust added most to Illinois Tool Works in Q1 2024, an estimated $224M increase.
- Northern Trust's biggest Q1 2024 reduction was Apple, cutting an estimated $1.44B.
- Northern Trust fully exited Splunk Inc in Q1 2024, selling an estimated $163M.
- Northern Trust's ten largest holdings make up 25% of its $579B portfolio in Q1 2024.
- Northern Trust opened 95 new positions and closed 140 in Q1 2024.
- Northern Trust's portfolio value rose 4.8% quarter-over-quarter to $579B.
Based on Northern Trust's 13F filing for Q1 2024, filed 14 May 2024.